Where you can work from
Location not specified
The listing does not say where you can work from. Missing information is not the same as worldwide: check before applying.
The company's headquarters is not the same as where you may work from. Visa sponsorship only matters if you would relocate; see below.
Visa sponsorship, if you would relocate
Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 1 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Apr 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Iovance Biotherapeutics INC paid sponsored hires in similar roles1 certified filing for “Director, IT Infrastructure and Operations” (Software Developers) in CA: $258k–$258k, median $258k.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 1 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Apr 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Iovance Biotherapeutics INC paid sponsored hires in similar roles
- 1 certified filing for “Director, IT Infrastructure and Operations” (Software Developers) in CA: $258k–$258k, median $258k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
About Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics , Inc. is the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) cell therapies for patients with solid tumors. Amtagvi® (lifileucel) is the first FDA-approved, one-time treatment for previously treated advanced melanoma, now approved in three global markets and available at more than 95 authorized treatment centers. The Iovance TIL platform spans registrational trials and next-generation programs in additional solid tumors, including gene-edited and IL-12 tethered TIL therapies, next-generation IL-2, and precision immuno-oncology approaches. As the first and only company to take TIL therapy from concept to a broadly accessible commercial treatment, Iovance operates as an end-to-end cell therapy company, anchored by fully owned, centralized U.S.-based manufacturing that is scaled to serve thousands of cancer patients worldwide each year. For more information, please visit www.iovance.com .
Amtagvi® and its accompanying design marks, Proleukin ® , Iovance ® , and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks and registered trademarks are the property of their respective owners.
Information on Iovance’s broad, industry-leading patent portfolio is available on the Intellectual Property page on www.iovance.com .
Overview
The associate director, Publications, is a core member of the Medical affairs team and will report to the Director of publications. This role will support the development and execution of publication plans, including incorporation of strategic digital extenders, for their assigned therapeutic area. The Associate Director, Publications works closely with various functional areas within the organization to communicate accurate, consistent, and timely information regarding products and therapeutic areas. This role will have high visibility with the leadership and requires the ability to lead cross-functional teams in a matrixed organization. The Associate Director will work closely with the cross-functional data generation team (Clinical development, HEOR, Biometrics, preclinical and research) and engage with healthcare professional experts and authors. The role will ensure compliance with publication-related policies and procedures.
Essential Functions and Responsibilities
• Subject matter expert and internal liaison for the assigned therapeutic area(s) with ability to work independently and lead/ influence cross-functionally.
• Support and facilitate comprehensive cross-functional global publication planning, including generation and execution of annual publication plans and presence at scientific congresses, with an understanding of how these activities support the overall business strategy, and including identification and prioritization of regional and local publication needs
• Execute publication plans including partnering with agency partners to ensure delivery of accurate and appropriate publications on time, within budget, and adhering to policy
• Partner with Scientific Communications lead to support the incorporation of published data into medical materials (e.g., field medical, medical affairs training)
• Ensure the publication development process and all materials produced are in compliance with Iovance policy and guidelines including ICMJE, PhRMA, and GPP
• Leverage best practices and implement efficient processes to optimize publication efforts across medical affairs
• Support the execution and implementation of iEnvision for publications management
• Must adhere to Iovance Biotherapeutics’ core values, policies, procedures, and business ethics.
• Perform miscellaneous duties as assigned.
Required Ed
Apply on employer site ↗